MedKoo Cat#: 592776 | Name: Estrandron

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Estrandron is a drug containing testosterone, estradiol or their derivatives; reported in eastern European literature.

Chemical Structure

 Estrandron
Estrandron
CAS#75026-40-3

Theoretical Analysis

MedKoo Cat#: 592776

Name: Estrandron

CAS#: 75026-40-3

Chemical Formula: C47H70O6

Exact Mass: 730.5172

Molecular Weight: 731.07

Elemental Analysis: C, 77.22; H, 9.65; O, 13.13

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Estrandron
IUPAC/Chemical Name
Androst-4-en-3-one, 17-((4-methyl-1-oxopentyl)oxy)-, (17beta)-, mixt. with (17beta)-17-(1-oxopropoxy)androst-4-en-3-one
InChi Key
ONMPQVOXSSXUIO-CDVOLGSESA-N
InChi Code
InChI=1S/C25H38O3.C22H32O3/c1-16(2)5-10-23(27)28-22-9-8-20-19-7-6-17-15-18(26)11-13-24(17,3)21(19)12-14-25(20,22)4;1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h15-16,19-22H,5-14H2,1-4H3;13,16-19H,4-12H2,1-3H3/t19-,20+,21-,22-,24-,25-;16-,17+,18-,19-,21-,22-/m00/s1
SMILES Code
CCC(O[C@@H](CC[C@@H]1[C@@H]2CCC3=C4)[C@@]1(C)CC[C@@H]2[C@@]3(C)CCC4=O)=O.CC(C)CCC(O[C@@H](CC[C@@H]5[C@@H]6CCC7=C8)[C@@]5(C)CC[C@@H]6[C@@]7(C)CCC8=O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 731.07 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Akhmerov NU. [Various pathogenetic mechanisms of cleidocranial dysostosis]. Zh Nevropatol Psikhiatr Im S S Korsakova. 1983;83(5):678-81. Russian. PubMed PMID: 6880493. 2: MOLNAR G, KISS E. [RESULTS OF THE TREATMENT WITH AMBOSEX IN FEMALE URINARY INCONTINENCE]. Magy Noorv Lapja. 1964 Jan;27:18-21. Hungarian. PubMed PMID: 14128081. 3: Goligorskii MS, Datsenko ZM, Volkov GL. [Effect of estrogens and androgens on calcium transport in experimental chronic renal failure]. Vopr Med Khim. 1980 Jul-Aug;26(4):449-51. Russian. PubMed PMID: 6893882. 4: SAS M, FARKAS M, SZEGVARI M. [TREATMENT OF A MENOPAUSAL SYNDROME WITH A COMBINED ESTROGEN-ANDROGEN (AMBOSEX) PREPARATION]. Magy Noorv Lapja. 1963 Nov;26:337-43. Hungarian. PubMed PMID: 14108052.